Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Sales | 130,688 | 83,494 |
| Cost of Goods | 31,603 | 30,102 |
| Gross Profit | 99,085 | 53,392 |
| Operating Expenses | 88,352 | 40,542 |
| Operating Income | 11,336 | 12,952 |
| Interest Expense | 767 | 241 |
| Other Income | 10,540 | 3,890 |
| Pre-tax Income | 21,109 | 16,601 |
| Income Tax | 5,325 | 5,129 |
| Net Income Continuous | 15,784 | 11,472 |
| Net Income | $15,784 | $11,472 |
| EPS Basic Total Ops | 0.77 | 0.61 |
| EPS Basic Continuous Ops | 0.77 | 0.61 |
| EPS Diluted Total Ops | 0.69 | 0.56 |
| EPS Diluted Continuous Ops | 0.69 | 0.56 |
| EBITDA(a) | $14,885 | $14,819 |